Fiserv: Potential Asset Sales, Activists, And Clover Outweigh Missteps

Seeking Profits 5.68K Followers Follow Summary Fiserv remains a 'Strong Buy,' with pessimism priced in and significant asset value, notably in Clover. Activist pressure and potential asset sales, including the debit card network, could unlock value and catalyze a re-rating. Recent results show margin compression and revenue declines, but margin recovery and revenue growth are expected in late 2026 and 2027. FISV trades at ~7x earnings, with a $70 price target supported by Clover’s $35 billion valuation and positive revenue inflection as a key catalyst. Getty Images Shares of Fiserv ( FISV ) have been a poor performer over the past year, losing over half their value. The stock has seen a dramatic re-rating as much of its organic growth was due to Argentinian inflation, rather than core business strength. We have This article was written by Seeking Profits 5.68K Followers Follow Over fifteen years of experience making contrarian bets based on my macro view and stock-specific turnaround stories to garner outsized returns with a favorable risk/reward profile. If you want me to cover a specific stock or have a question for an article, just let me know! Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.